Selective Thrombin Modulation by AYA1809002: Stability and On-Demand Reversal of an Exosite I-Targeting Aptamer
Mohamad Ammar Ayass, Natalya Griko, Victor Pashkov, Jin Zhang, Ghulam Abbas, Tutku Okyay, Kevin Zhu, Lina Abi-Mosleh · 2026
Read Selective Thrombin Modulation by AYA1809002: Stability and On-Demand Reversal of an Exosite I-Targeting Aptamer by Mohamad Ammar Ayass, Natalya Griko, Victor Pashkov, Jin Zhang, Ghulam Abbas, Tutku Okyay, Kevin Zhu, Lina Abi-Mosleh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610730.txt.
Description
Mohamad Ammar Ayass and co-authors test a short strand of DNA, called AYA1809002, that can tune thrombin, a key driver of blood clotting. Common drugs that block thrombin shut down all of its work, which can upset both clot forming and clot control signals.
The strand binds one side site on thrombin and slows clot forming, while it leaves other jobs of the enzyme intact. It showed no action on a set of like enzymes, and it held up well in blood serum and under heat, acid, and light stress. A matching strand could switch its effect off fast when needed.
Catalog record
| CREATOR | Mohamad Ammar Ayass, Natalya Griko, Victor Pashkov, Jin Zhang, Ghulam Abbas, Tutku Okyay, Kevin Zhu, Lina Abi-Mosleh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |